You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 10, 2024

Claims for Patent: 8,975,471


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,975,471
Title:MicroRNAs
Abstract: The invention provides methods and compositions useful in target sequence suppression, target sequence validation and target sequence down regulation. The invention provides polynucleotide constructs useful for gene silencing or RNA down regulation, as well as cells, plants and seeds comprising the polynucleotides. The invention also provides a method for using microRNA to silence a target sequence or to down regulate RNA.
Inventor(s): Reyes Taboada; Jose L. (Mexico City, MX), Zhang; Xiuren (New York, NY), Soyano; Takashi (New York, NY), Chua; Nam-Hai (New York, NY), Niu; Qi-Wen (Staten Island, NY), Lin; Shih-Shun (New York, NY)
Assignee: The Rockefeller University (New York, NY)
Application Number:11/247,587
Patent Claims:1. A method of obtaining a disease resistant plant by down regulating a target sequence of a plant virus or plant viroid in a plant, consisting of: (a) transforming a plant cell susceptible to infection by the plant virus or plant viroid with a nucleic acid construct comprising a promoter functional in a plant cell operably linked to a polynucleotide, wherein the polynucleotide encodes one or more modified miRNA precursors, wherein each modified miRNA precursor comprises a fragment of a plant miRNA primary transcript that is modified in the miRNA sequence and the miRNA complementary sequence, wherein the plant miRNA primary transcript is a plant miR159 primary transcript, further wherein each modified miRNA precursor is capable of forming a first double-stranded RNA or a hairpin, wherein each modified miRNA is an miRNA modified to be (i) fully complementary to a target sequence, (ii) fully complementary to a target sequence except for GU base pairing or (iii) fully complementary to a target sequence in the first ten nucleotides counting from the 5' end of the miRNA, wherein the target sequence of each modified miRNA is the same or different, and wherein at least one target sequence encodes a gene silencing suppressor of a plant virus or plant viroid and wherein the modified miRNA sequence targeting said gene silencing suppressor consists of (i) the nucleotide sequence of SEQ ID NO:162 or (ii) a nucleotide sequence that is at least 90% identical to the nucleotide sequence of SEQ ID NO:162; (b) obtaining a transgenic plant from the transformed plant cell of (a); (c) expressing the nucleic acid construct in the transgenic plant of (b) for a time sufficient to produce each modified miRNA, wherein each modified miRNA binds to its target sequence to form a second double-stranded RNA which is cleaved thereby down regulating the target sequence; and (d) selecting a transgenic plant of (c) that is resistant to a plant virus or plant viroid, wherein the plant virus or plant viroid comprises the at least one target sequence that encodes the gene silencing suppressor and wherein the resistant transgenic plant shows no symptoms of infection.

2. The method of claim 1, wherein the cell is from a plant selected from the group consisting of corn, wheat, rice, barley, oats, sorghum, millet, sunflower, safflower, cotton, soy, canola, alfalfa, Arabidopsis, and tobacco.

3. The method of claim 1, wherein the modified miRNA is a plant miRNA modified to be fully complementary to the target sequence.

4. The method of claim 1, wherein the promoter is a pathogen-inducible promoter.

5. The method of claim 1, wherein the nucleic acid construct encodes two or more modified miRNA precursor sequences.

6. The method of claim 5, wherein the nucleic acid construct encodes a hetero-polymeric precursor miRNA or a homo-polymeric precursor miRNA.

7. The method of claim 1, wherein the nucleic acid construct is inserted into an intron of a gene or transgene of the plant cell.

8. The method of claim 3, wherein the cell is from a plant selected from the group consisting of corn, wheat, rice, barley, oats, sorghum, millet, sunflower, safflower, cotton, soy, canola, alfalfa, Arabidopsis, and tobacco.

9. The method of claim 2, wherein the plant miRNA is from a plant selected from the group consisting of Arabidopsis, tomato, soybean, rice, and corn.

10. The method of claim 3, wherein the promoter is a pathogen-inducible promoter.

11. The method of claim 3, wherein the nucleic acid construct encodes two or more modified miRNA precursor sequences.

12. The method of claim 4, wherein the nucleic acid construct encodes two or more modified miRNA precursor sequences.

13. The method of claim 1, wherein the nucleotide sequence (ii) is at least 95% identical to the nucleotide sequence of SEQ ID NO:162.

14. The method of claim 13, wherein the nucleic acid construct encodes two or more modified miRNA precursor sequences.

15. The method of claim 11, wherein the nucleic acid construct encodes a hetero-polymeric precursor miRNA or a homo-polymeric precursor miRNA.

16. The method of claim 12, wherein the nucleic acid construct encodes a hetero-polymeric precursor miRNA or a homo-polymeric precursor miRNA.

17. The method of claim 14, wherein the nucleic acid construct encodes a hetero-polymeric precursor miRNA or a homo-polymeric precursor miRNA.

18. The method of claim 3, wherein the nucleic acid construct is inserted into an intron of a gene or transgene of the cell.

19. The method of claim 4, wherein the cell is from a plant selected from the group consisting of corn, wheat, rice, barley, oats, sorghum, millet, sunflower, safflower, cotton, soy, canola, alfalfa, Arabidopsis, and tobacco.

20. The method of claim 4, wherein the nucleic acid construct is inserted into an intron of a gene or transgene of the cell.

21. The method of claim 5, wherein the cell is from a plant selected from the group consisting of corn, wheat, rice, barley, oats, sorghum, millet, sunflower, safflower, cotton, soy, canola, alfalfa, Arabidopsis, and tobacco.

22. The method of claim 6, wherein the cell is from a plant selected from the group consisting of corn, wheat, rice, barley, oats, sorghum, millet, sunflower, safflower, cotton, soy, canola, alfalfa, Arabidopsis, and tobacco.

23. The method of claim 5, wherein the nucleic acid construct is inserted into an intron of a gene or transgene of the cell.

24. The method of claim 7, wherein the cell is from a plant selected from the group consisting of corn, wheat, rice, barley, oats, sorghum, millet, sunflower, safflower, cotton, soy, canola, alfalfa, Arabidopsis, and tobacco.

25. The method of claim 13, wherein the cell is from a plant selected from the group consisting of corn, wheat, rice, barley, oats, sorghum, millet, sunflower, safflower, cotton, soy, canola, alfalfa, Arabidopsis, and tobacco.

26. The method of claim 13, wherein the promoter is a pathogen-inducible promoter.

27. The method of claim 13, wherein the nucleic acid construct is inserted into an intron of a gene or transgene of the cell.

28. The method of claim 8, wherein the plant miRNA is from a plant selected from the group consisting of Arabidopsis, tomato, soybean, rice, and corn.

29. The method of claim 19, wherein the plant miRNA is from a plant selected from the group consisting of Arabidopsis, tomato, soybean, rice, and corn.

30. The method of claim 21, wherein the plant miRNA is from a plant selected from the group consisting of Arabidopsis, tomato, soybean, rice, and corn.

31. The method of claim 22, wherein the plant miRNA is from a plant selected from the group consisting of Arabidopsis, tomato, soybean, rice, and corn.

32. The method of claim 24, wherein the plant miRNA is from a plant selected from the group consisting of Arabidopsis, tomato, soybean, rice, and corn.

33. The method of claim 25, wherein the plant miRNA is from a plant selected from the group consisting of Arabidopsis, tomato, soybean, rice, and corn.

Details for Patent 8,975,471

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2039-02-26
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2039-02-26
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2039-02-26
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.